Your browser doesn't support javascript.
loading
Quality gap in venous thromboembolism prophylaxis practices in inpatients: Assessment of prophylaxis practices in a University Hospital.
Güven, Alper Tuna; Altintop, Sabri Engin; Özdede, Murat; Uyaroglu, Oguz Abdullah; Tanriöver, Mine Durusu.
Afiliação
  • Güven AT; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Hacettepe district, Ankara 06230, Turkey.
  • Altintop SE; Department of Internal Medicine, Hacettepe University Faculty of Medicine, Hacettepe district, Ankara 06230, Turkey.
  • Özdede M; Department of Internal Medicine, Division of General Internal Medicine, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey.
  • Uyaroglu OA; Department of Internal Medicine, Division of General Internal Medicine, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey.
  • Tanriöver MD; Department of Internal Medicine, Division of General Internal Medicine, Hacettepe University Faculty of Medicine, Ankara 06230, Turkey.
Int J Qual Health Care ; 33(3)2021 Jul 28.
Article em En | MEDLINE | ID: mdl-34270730
BACKGROUND: Venous thromboembolism (VTE) is a prevalent complication of inpatient care, causing high burden of morbidity and mortality. Prophylaxis reduces the events; thus, these practices are promoted. We aimed to assess the VTE prophylaxis practices in the general internal medicine wards of a tertiary-care university hospital and utilize these data to propose quality improvement projects. OBJECTIVE: Assess the pharmacological venous thromboembolism prophylaxis utilization by using the Padua Prediction Score and demonstrate the main determinants of inappropriate prophylaxis use. METHODS: Electronic medical records were used to collect data cross-sectionally from 1 January 2019 to 30 June 2019. Padua Prediction Score was used to assess the appropriateness of VTE prophylaxis. Underlying health conditions, hospitalization causes, anti-platelets and use of glucocorticoids were also assessed as confounding factors. RESULTS: A total of 295 patients were included. Higher proportion of patients who received VTE prophylaxis were obese and had higher rates of diabetes and coronary artery disease. Prophylaxis was more commonly utilized among patients who were elderly, obese, having an acute infection and/or rheumatologic disorder and prolonged bed rest (P ≤ 0.001, P = 0.01, P = 0.22 and P ≤ 0.001, respectively). Thirty-five patients (11.8%) received VTE prophylaxis, despite 89 patients (30.2%) were high-risk patients. In the high-risk group (n = 89), 27 patients (30.3%) received appropriate pharmacological prophylaxis, while 8 patients (3.9%) received VTE prophylaxis in the low-risk group (total n = 206). A considerable percentage of the high-risk population (69.6%) did not receive VTE prophylaxis. DISCUSSION: Underuse constitutes a major challenge in our hospital but differing from other institutions, overuse is not a significant issue. Further studies are needed whether VTE prophylaxis improvement implementations uniformly increase appropriate VTE use.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tromboembolia Venosa Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article